p21 Rabbit Polyclonal Antibody
To Order Contact us: [email protected]
p21 Polyclonal Antibody |
|||
ES3100-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against p21 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
p21 Polyclonal Antibody |
|||
ES8265-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against p21 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC |
p21 Polyclonal Antibody |
|||
ES8265-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against p21 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC |
p21 Polyclonal Antibody |
|||
41297-100ul | SAB | 100ul | EUR 302.4 |
p21 Polyclonal Antibody |
|||
41297-50ul | SAB | 50ul | EUR 224.4 |
p21 Polyclonal Antibody |
|||
ABP52101-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of p21 from Human, Mouse, Rat. This p21 antibody is for WB, IF, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human p21 around the non-phosphorylation site of T145 |
p21 Polyclonal Antibody |
|||
ABP52101-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of p21 from Human, Mouse, Rat. This p21 antibody is for WB, IF, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human p21 around the non-phosphorylation site of T145 |
p21 Polyclonal Antibody |
|||
ABP52101-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of p21 from Human, Mouse, Rat. This p21 antibody is for WB, IF, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human p21 around the non-phosphorylation site of T145 |
p21 Polyclonal Antibody |
|||
Ab18278-100 | GenDepot | 100ul | EUR 578.4 |
P21 Polyclonal Antibody |
|||
EA236-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against P21 from Human/ Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IHC |
P21 Polyclonal Antibody |
|||
EA236-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against P21 from Human/ Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IHC |
P21 Polyclonal Antibody |
|||
A71110-050 | EpiGentek | 50 ul | EUR 377.3 |
P21 Polyclonal Antibody |
|||
A71110-100 | EpiGentek | 100 ul | EUR 577.5 |
P21 Polyclonal Antibody |
|||
A71110 | EpiGentek |
|
|
p21 Rabbit pAb |
|||
A1483-100ul | Abclonal | 100 ul | EUR 369.6 |
p21 Rabbit pAb |
|||
A1483-200ul | Abclonal | 200 ul | EUR 550.8 |
p21 Rabbit pAb |
|||
A1483-20ul | Abclonal | 20 ul | EUR 219.6 |
p21 Rabbit pAb |
|||
A1483-50ul | Abclonal | 50 ul | EUR 267.6 |
Anti-p21 Rabbit Monoclonal Antibody |
|||
M00145-2 | BosterBio | 100ug/vial | EUR 476.4 |
Description: Rabbit Monoclonal p21 Antibody. Validated in IF, ICC, WB and tested in Human, Mouse, Rat. |
Anti-p21 Rabbit Monoclonal Antibody |
|||
M00145-3 | BosterBio | 100ug/vial | EUR 476.4 |
Description: Rabbit Monoclonal p21 Antibody. Validated in IP, IF, IHC, WB and tested in Human. |
P21 Polyclonal Conjugated Antibody |
|||
C30427 | SAB | 100ul | EUR 476.4 |
Rabbit p21 ELISA Kit |
|||
ERTA0011 | Abclonal | 96Tests | EUR 625.2 |
p21 antibody |
|||
70R-49526 | Fitzgerald | 100 ul | EUR 292.8 |
Description: Purified Polyclonal p21 antibody |
P21 antibody |
|||
70R-21429 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal P21 antibody |
p21 Antibody |
|||
39261-100ul | SAB | 100ul | EUR 468 |
p21 Antibody |
|||
35343-100ul | SAB | 100ul | EUR 468 |
p21 antibody |
|||
10R-8571 | Fitzgerald | 100 ul | EUR 471.6 |
Description: Mouse monoclonal p21 antibody |
p21 antibody |
|||
10-2558 | Fitzgerald | 250 ug | EUR 590.4 |
Description: Mouse monoclonal p21 antibody |
p21 Antibody |
|||
20-abx133461 | Abbexa |
|
|
p21 Antibody |
|||
20-abx133946 | Abbexa |
|
|
p21 Antibody |
|||
20-abx009455 | Abbexa |
|
|
p21 Antibody |
|||
abx037363-100ug | Abbexa | 100 ug | EUR 469.2 |
P21 Antibody |
|||
abx236066-100ug | Abbexa | 100 ug | EUR 610.8 |
p21 Antibody |
|||
F51647-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
p21 Antibody |
|||
F51647-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
p21 Antibody |
|||
F52199-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
p21 Antibody |
|||
F52199-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
p21 (phospho Thr145) Polyclonal Antibody |
|||
ES1377-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against p21 (phospho Thr145) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
p21 (phospho Thr145) Polyclonal Antibody |
|||
ES1377-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against p21 (phospho Thr145) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
[KO Validated] P21 Polyclonal Antibody |
|||
30427-100ul | SAB | 100ul | EUR 302.4 |
[KO Validated] P21 Polyclonal Antibody |
|||
30427-50ul | SAB | 50ul | EUR 224.4 |
p21 (phospho Thr145) Polyclonal Antibody |
|||
ABP50378-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of p21 phospho Thr145) from Human, Mouse, Rat. This p21 phospho Thr145) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human p21 around the phosphorylation site of T145 |
p21 (phospho Thr145) Polyclonal Antibody |
|||
ABP50378-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of p21 phospho Thr145) from Human, Mouse, Rat. This p21 phospho Thr145) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human p21 around the phosphorylation site of T145 |
p21 (phospho Thr145) Polyclonal Antibody |
|||
ABP50378-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of p21 phospho Thr145) from Human, Mouse, Rat. This p21 phospho Thr145) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human p21 around the phosphorylation site of T145 |
[KO Validated] P21 Rabbit pAb |
|||
A2691-100ul | Abclonal | 100 ul | EUR 492 |
[KO Validated] P21 Rabbit pAb |
|||
A2691-200ul | Abclonal | 200 ul | EUR 685.2 |
[KO Validated] P21 Rabbit pAb |
|||
A2691-20ul | Abclonal | 20 ul | EUR 265.2 |
[KO Validated] P21 Rabbit pAb |
|||
A2691-50ul | Abclonal | 50 ul | EUR 344.4 |
[KO Validated] p21 Rabbit mAb |
|||
A19094-100ul | Abclonal | 100 ul | EUR 492 |
[KO Validated] p21 Rabbit mAb |
|||
A19094-200ul | Abclonal | 200 ul | EUR 685.2 |
[KO Validated] p21 Rabbit mAb |
|||
A19094-20ul | Abclonal | 20 ul | EUR 265.2 |
[KO Validated] p21 Rabbit mAb |
|||
A19094-50ul | Abclonal | 50 ul | EUR 344.4 |
Polyclonal p21 (CDKN1A) Antibody (C-term) |
|||
APR05925G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human p21 (CDKN1A) (C-term). This antibody is tested and proven to work in the following applications: |
p21 Cip1 Antibody |
|||
DF6423 | Affbiotech | 200ul | EUR 420 |
p21 Cip1 Antibody |
|||
AF6290 | Affbiotech | 200ul | EUR 420 |
anti- P21 antibody |
|||
FNab06066 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against P21 |
p21 ARC antibody |
|||
70R-12631 | Fitzgerald | 100 ul | EUR 548.4 |
Description: Affinity purified Rabbit polyclonal p21 ARC antibody |
p21-ARC antibody |
|||
22102-100ul | SAB | 100ul | EUR 468 |
p21 (pT145) Antibody |
|||
20-abx121342 | Abbexa |
|
|
p21 Cip1 Antibody |
|||
abx012051-100ug | Abbexa | 100 ug | EUR 526.8 |
p21 Cip1 Antibody |
|||
ABF6290 | Lifescience Market | 100 ug | EUR 525.6 |
P21;CDKN1A Antibody |
|||
abx236067-100ug | Abbexa | 100 ug | EUR 577.2 |
Anti-p21 antibody |
|||
STJ94862 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: p21 is a protein encoded by the CDKN1A gene which is approximately 18,1 kDa. p21 is localised to the cytoplasm and nucleus. It is involved in CDK-mediated phosphorylation and removal of Cdc6, RET signalling, cyclins and cell cycle regulation. It may be involved in p53/TP53 mediated inhibition of cellular proliferation in response to DNA damage. It binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression. It also functions in the nuclear localization and assembly of cyclin D-CDK4 complex and promotes its kinase activity towards RB1. p21 is expressed in all adult tissues, with lower levels expressed in the brain. Mutations in the CDKN1A gene may result in pancreatic cancer and ovarian cancer. STJ94862 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This polyclonal antibody detects endogenous levels of p21 protein. |
Anti-p21 antibody |
|||
STJ97470 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: p21 is a protein encoded by the CDKN1A gene which is approximately 18,1 kDa. p21 is localised to the cytoplasm and nucleus. It is involved in CDK-mediated phosphorylation and removal of Cdc6, RET signalling, GAB1 signalosome and cell cycle regulation. This protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and functions as a regulator of cell cycle progression at G1. p21 is expressed in all adult tissues. Mutations in the CDKN1A gene may result in pancreatic cancer and ovarian cancer. STJ97470 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody detects endogenous p21 protein. |
p21 Antibody / CDKN1A |
|||
F54670-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
p21 Antibody / CDKN1A |
|||
F54670-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
p21 Antibody / CDKN1A |
|||
F54937-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
p21 Antibody / CDKN1A |
|||
F54937-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
p21 Antibody / CDKN1A |
|||
V2085-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This antibody recognizes a 21kDa protein, identified as the p21 or p21WAF1 tumor suppressor protein. This antibody is highly specific and shows no cross-reaction with other closely related mitotic inhibitors. p21 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. p21 expression is induced by the wild type, but not mutant, p53. Normal cells generally display a rather intense nuclear expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2085-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This antibody recognizes a 21kDa protein, identified as the p21 or p21WAF1 tumor suppressor protein. This antibody is highly specific and shows no cross-reaction with other closely related mitotic inhibitors. p21 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. p21 expression is induced by the wild type, but not mutant, p53. Normal cells generally display a rather intense nuclear expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2085IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This antibody recognizes a 21kDa protein, identified as the p21 or p21WAF1 tumor suppressor protein. This antibody is highly specific and shows no cross-reaction with other closely related mitotic inhibitors. p21 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. p21 expression is induced by the wild type, but not mutant, p53. Normal cells generally display a rather intense nuclear expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2085SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This antibody recognizes a 21kDa protein, identified as the p21 or p21WAF1 tumor suppressor protein. This antibody is highly specific and shows no cross-reaction with other closely related mitotic inhibitors. p21 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. p21 expression is induced by the wild type, but not mutant, p53. Normal cells generally display a rather intense nuclear expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
F54392-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
p21 Antibody / CDKN1A |
|||
F54392-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
p21 Antibody / CDKN1A |
|||
V3802-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This MAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V3802-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This MAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This MAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V3802SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This MAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V7072-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V7072-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V7072IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V7072SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V7655-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This MAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V7655-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This MAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This MAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V7655SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This MAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2431-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2431-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2431IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2431SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2432-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2432-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2432IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2432SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2433-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2433-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2433IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2433SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2434-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. It is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2434-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. It is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2434IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. It is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V2434SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. It is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V3549-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V3549-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V3549IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V3549SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This mAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V3550-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein, expressed by the CDNK1A gene. This mAb is highly specific to CDNK1A/p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of CDNK1A expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V3550-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein, expressed by the CDNK1A gene. This mAb is highly specific to CDNK1A/p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of CDNK1A expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V3550IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein, expressed by the CDNK1A gene. This mAb is highly specific to CDNK1A/p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of CDNK1A expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V3550SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein, expressed by the CDNK1A gene. This mAb is highly specific to CDNK1A/p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk's and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of CDNK1A expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V8615-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This MAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V8615-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This MAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This MAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
p21 Antibody / CDKN1A |
|||
V8615SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This MAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
Rabbit Antioncogene p21 protein ELISA kit |
|||
E04A0004-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Rabbit Antioncogene p21 protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Antioncogene p21 protein ELISA kit |
|||
E04A0004-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Rabbit Antioncogene p21 protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Antioncogene p21 protein ELISA kit |
|||
E04A0004-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Rabbit Antioncogene p21 protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
p21 Cip1 (Phospho-Ser129) Polyclonal Conjugated Antibody |
|||
C12621 | SAB | 100ul | EUR 476.4 |
Polyclonal CDKN1A / WAF1 / p21 Antibody (aa111-160) |
|||
APR03216G | Leading Biology | 0.05ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CDKN1A / WAF1 / p21 (aa111-160). This antibody is tested and proven to work in the following applications: |
p21 protein |
|||
E20-80075 | EnoGene | 20ug | EUR 489.6 |
p21 protein |
|||
E20-80076 | EnoGene | 20ug | EUR 489.6 |